IMMAGE BIOTHERAPEUTICS CORP.: 10-Q filed 2015-03-30

Name: IMMAGE BIOTHERAPEUTICS CORP.: 10-Q filed 2015-03-30
Creator: IMMAGE BIOTHERAPEUTICS CORP.

What IMMAGE BIOTHERAPEUTICS CORP. reported in its quarterly report filed 2015-03-30 (fiscal Q1 2015): 12 published measures, 25 facts as tagged in accession 0001477932-15-001969.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-03-30
Fiscal period: fiscal Q1 2015
Accession: 0001477932-15-001969 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IMMAGE BIOTHERAPEUTICS CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-12-31	23	USD
At 2014-09-30	2,342	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-12-31	23	USD
At 2014-09-30	2,342	USD
At 2013-12-31	833	USD
At 2013-09-30	7,215	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	-9,669	USD	92
2012-06-21 to 2014-12-31	-42,156	USD	924
2013-10-01 to 2013-12-31	-10,625	USD	92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	-2,318	USD	92
2013-10-01 to 2013-12-31	-8,843	USD	92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	2,461	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-12-31	42,156	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	-9,669	USD	92
2013-10-01 to 2013-12-31	-10,625	USD	92

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-12-31	31,307	USD
At 2014-09-30	23,957	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2014-12-31	-31,284	USD
At 2014-09-30	-21,615	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2014-12-31	0	USD
At 2013-12-31	0	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	2,034	USD	92
2013-10-01 to 2013-12-31	2,204	USD	92

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	7,351	USD	92
2013-10-01 to 2013-12-31	1,782	USD	92

Inspect the source

Entity: IMMAGE BIOTHERAPEUTICS CORP. / CIK 0001564273
Captured: 2026-09-23 03:00 UTC
SEC response SHA-256: 76b05bb10042aafcff9e5410669c161498d0cb2a1a3e0078501d457e3630a630

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001564273.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))